Covered recipient · General Payments record
BELDA ZAMORA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$575.22
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $265.59 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $95.13 | 5 |
| Kowa Pharmaceuticals America, Inc. | $63.26 | 3 |
| Novo Nordisk AS | $33.80 | 2 |
| ABBVIE INC. | $32.58 | 1 |
| DEXCOM, INC. | $23.47 | 1 |
| Amgen Inc. | $17.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.58 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106390030 | CMS |
| Amgen Inc. | $17.35 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117421794 | CMS |
| Dexcom, Inc. | $23.47 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153285392 | CMS |
| Kowa Pharmaceuticals America, Inc. | $16.60 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113471863 | CMS |
| Kowa Pharmaceuticals America, Inc. | $24.54 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113471865 | CMS |
| Kowa Pharmaceuticals America, Inc. | $22.12 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113471867 | CMS |
| Lilly USA, LLC | $16.23 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136063822 | CMS |
| Lilly USA, LLC | $17.09 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136065616 | CMS |
| Lilly USA, LLC | $23.88 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136065618 | CMS |
| Lilly USA, LLC | $14.96 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136064542 | CMS |
| Lilly USA, LLC | $22.97 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136064714 | CMS |
| Novo Nordisk Inc | $13.33 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096953832 | CMS |
| Novo Nordisk Inc | $20.47 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096858503 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.